Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

Overview

Journal Pediatr Infect Dis J

Specialty Pediatrics

Date 2021 Aug 22

PMID 34420008

Authors

John Hansen

Michael D Decker

Edwin Lewis

Bruce Fireman

Vitali Pool

David P Greenberg

David R Johnson

Steven Black

Nicola P Klein

Affiliations

Soon will be listed here.

Abstract

Background: Hypotonic-hyporesponsive episode (HHE) after whole cell pertussis vaccination is a known adverse event. Less is known about the risk of HHE after administration of acellular pertussis vaccines.

Methods: Using parental interviews, this study actively surveyed for HHE among infants after doses 1 and 2 of acellular pertussis vaccine.

Results: We interviewed the parents of 52,531 infants. HHE was reported at a rate of 22.8 per 100,000 doses (95% CI: 11.8-39.9) of acellular pertussis vaccine, approximately 45 episodes per 100,000 children.

Conclusions: These rates are lower than HHE rates reported after whole cell pertussis vaccines and within the range of HHE rates reported in other studies of acellular pertussis vaccines.

References

Olin P, Rasmussen F, Gustafsson L, Hallander H, Heijbel H . Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet. 1997; 350(9091):1569-77. DOI: 10.1016/s0140-6736(97)06508-2. View

Bonhoeffer J, Gold M, Heijbel H, Vermeer P, Blumberg D, Braun M . Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2004; 22(5-6):563-8. DOI: 10.1016/j.vaccine.2003.09.009. View

Braun M, Terracciano G, Salive M, Blumberg D, Vermeer-de Bondt P, Heijbel H . Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics. 1998; 102(5):E52. DOI: 10.1542/peds.102.5.e52. View

. Recommended childhood immunization schedule--United States, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51(2):31-3. View

Gustafsson L, Hallander H, Olin P, Reizenstein E, Storsaeter J . A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996; 334(6):349-55. DOI: 10.1056/NEJM199602083340602. View

Atkinson W, Pickering L, Schwartz B, Weniger B, Iskander J, Watson J . General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep. 2002; 51(RR-2):1-35. View

Zhang L, Prietsch S, Axelsson I, Halperin S . Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2014; (9):CD001478. PMC: 9722541. DOI: 10.1002/14651858.CD001478.pub6. View

Schmitt H, Schuind A, Knuf M, Beutel K, Schulte-Wissermann H, Gahr M . Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr. 1996; 129(5):695-701. DOI: 10.1016/s0022-3476(96)70152-x. View

DuVernoy T, Braun M . Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics. 2000; 106(4):E52. DOI: 10.1542/peds.106.4.e52. View

10.

Buettcher M, Heininger U, Braun M, Bonhoeffer J, Halperin S, Heijbel H . Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2007; 25(31):5875-81. DOI: 10.1016/j.vaccine.2007.04.061. View

11.

Heijbel H, Ciofi Degli Atti M, HARZER E, Liese J, Preziosi M, Rasmussen F . Hypotonic hyporesponsive episodes in eight pertussis vaccine studies. Dev Biol Stand. 1997; 89:101-3. View

12.

Miller E . Overview of recent clinical trials of acellular pertussis vaccines. Biologicals. 1999; 27(2):79-86. DOI: 10.1006/biol.1999.0184. View